News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
677,747 Results
Type
Article (37988)
Company Profile (640)
Press Release (639119)
Multimedia
Podcasts (60)
Webinars (12)
Section
Business (201282)
Career Advice (2332)
Deals (36546)
Drug Delivery (109)
Drug Development (79314)
Employer Resources (170)
FDA (15946)
Job Trends (15120)
News (340228)
Policy (30705)
Tag
Academia (1859)
Academic (1)
Accelerated approval (5)
Adcomms (16)
Allergies (87)
Alliances (48370)
ALS (99)
Alzheimer's disease (1361)
Antibody-drug conjugate (ADC) (150)
Approvals (15927)
Artificial intelligence (279)
Autoimmune disease (29)
Automation (15)
Bankruptcy (378)
Best Places to Work (11308)
BIOSECURE Act (22)
Biosimilars (104)
Biotechnology (438)
Bladder cancer (82)
Brain cancer (26)
Breast cancer (274)
Cancer (2270)
Cardiovascular disease (187)
Career advice (1931)
Career pathing (32)
CAR-T (158)
Cell therapy (449)
Cervical cancer (20)
Clinical research (64833)
Collaboration (897)
Company closure (2)
Compensation (558)
Complete response letters (28)
COVID-19 (2456)
CRISPR (46)
C-suite (271)
Cystic fibrosis (105)
Data (2273)
Decentralized trials (2)
Denatured (5)
Depression (52)
Diabetes (270)
Diagnostics (6538)
Digital health (18)
Diversity (3)
Diversity, equity & inclusion (39)
Drug discovery (125)
Drug pricing (107)
Drug shortages (27)
Duchenne muscular dystrophy (97)
Earnings (84173)
Editorial (43)
Employer branding (24)
Employer resources (147)
Events (112495)
Executive appointments (766)
FDA (17275)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (782)
Gene editing (117)
Generative AI (25)
Gene therapy (324)
GLP-1 (755)
Government (3457)
Grass and pollen (6)
Guidances (142)
Healthcare (17366)
Huntington's disease (25)
IgA nephropathy (30)
Immunology and inflammation (139)
Indications (30)
Infectious disease (2602)
Inflammatory bowel disease (146)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (98)
Interviews (458)
IPO (17312)
IRA (43)
Job creations (4287)
Job search strategy (1603)
Kidney cancer (10)
Labor market (41)
Layoffs (552)
Leadership (21)
Legal (7761)
Liver cancer (73)
Lung cancer (324)
Lymphoma (142)
Machine learning (7)
Management (61)
Manufacturing (346)
MASH (75)
Medical device (13849)
Medtech (13854)
Mergers & acquisitions (19811)
Metabolic disorders (715)
Multiple sclerosis (85)
NASH (20)
Neurodegenerative disease (102)
Neuropsychiatric disorders (31)
Neuroscience (1939)
NextGen: Class of 2025 (6300)
Non-profit (2911)
Now hiring (41)
Obesity (382)
Opinion (254)
Ovarian cancer (76)
Pain (97)
Pancreatic cancer (87)
Parkinson's disease (152)
Partnered (21)
Patents (250)
Patient recruitment (118)
Peanut (48)
People (58354)
Pharmaceutical (132)
Pharmacy benefit managers (20)
Phase I (20389)
Phase II (28914)
Phase III (21424)
Pipeline (1360)
Policy (152)
Postmarket research (2044)
Preclinical (8349)
Press Release (67)
Prostate cancer (104)
Psychedelics (37)
Radiopharmaceuticals (263)
Rare diseases (396)
Real estate (5905)
Recruiting (68)
Regulatory (21585)
Reports (38)
Research institute (1804)
Resumes & cover letters (373)
Rett syndrome (4)
RNA editing (5)
RSV (45)
Schizophrenia (80)
Series A (140)
Series B (93)
Service/supplier (26)
Sickle cell disease (54)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (28)
Startups (3913)
State (2)
Stomach cancer (13)
Supply chain (71)
Tariffs (51)
The Weekly (54)
Vaccines (727)
Venture capitalists (45)
Weight loss (258)
Women's health (27)
Worklife (19)
Date
Last 7 days (952)
Last 30 days (3018)
Last 365 days (33263)
2025 (11948)
2024 (36271)
2023 (41072)
2022 (51942)
2021 (55932)
2020 (53195)
2019 (44604)
2018 (33927)
2017 (33528)
2016 (32176)
2015 (37772)
2014 (30308)
2013 (25016)
2012 (26662)
2011 (26899)
2010 (24434)
Location
Africa (744)
Alabama (60)
Alaska (7)
Arizona (174)
Arkansas (11)
Asia (41507)
Australia (6729)
California (6504)
Canada (2071)
China (553)
Colorado (275)
Connecticut (289)
Delaware (161)
Europe (90975)
Florida (924)
Georgia (212)
Hawaii (1)
Idaho (57)
Illinois (513)
India (29)
Indiana (329)
Iowa (12)
Japan (167)
Kansas (104)
Kentucky (25)
Louisiana (13)
Maine (66)
Maryland (858)
Massachusetts (4995)
Michigan (242)
Minnesota (415)
Mississippi (2)
Missouri (84)
Montana (30)
Nebraska (23)
Nevada (64)
New Hampshire (66)
New Jersey (1844)
New Mexico (30)
New York (1803)
North Carolina (1101)
North Dakota (8)
Northern California (2837)
Ohio (201)
Oklahoma (10)
Oregon (42)
Pennsylvania (1425)
Puerto Rico (14)
Rhode Island (35)
South America (1132)
South Carolina (24)
South Dakota (1)
Southern California (2381)
Tennessee (93)
Texas (954)
United States (24329)
Utah (188)
Virginia (155)
Washington D.C. (66)
Washington State (587)
West Virginia (3)
Wisconsin (58)
677,747 Results for "general electric company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve
March 3, 2025
·
4 min read
Two Mitsubishi Electric Researchers Elevated to IEEE Fellows, Class of 2024
Mitsubishi Electric Corporation announced that Dr. Shumpei Kameyama of Mitsubishi Electric’s Information Technology R&D Center and Dr. Jonathan Le Roux of Mitsubishi Electric Research Laboratories, Inc. have been awarded the title of IEEE Fellow.
February 14, 2024
·
1 min read
Press Releases
Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
April 23, 2025
·
5 min read
Press Releases
Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech
March 17, 2025
·
7 min read
Legal
Jazz Settles for $145M in Anti-Trust Suits Centering on Xyrem Generics
Jazz is being accused of anti-competitive practices regarding its narcolepsy drug, as generic competitors emerge on the market.
April 9, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Thermo Fisher Scientific Accelerates 100 Percent Renewable Electricity Goal for European Operations with New Solar Power Agreement with X-ELIO
February 4, 2025
·
4 min read
Genetown
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
Charles River Laboratories International, Inc. (NYSE: CRL) today announced it has reached 100 percent renewable electricity across all of its global sites as of the first quarter of 2024, significantly ahead of the original target date.
April 22, 2024
·
4 min read
Press Releases
Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments
May 7, 2025
·
4 min read
Press Releases
VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies
April 23, 2025
·
18 min read
Press Releases
Electric is the Future: Chronus Health to Unveil its Electrical Sensing-Based Blood Testing Technology at ADLM 2024
July 24, 2024
·
2 min read
1 of 67,775
Next
